ASKA Pharmaceutical Obtains Manufacturing Approval for Its New Painkiller Grelan Bit.Tokyo, Japan, Feb 15, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - ASKA ASKA Anti-Slipknot Army Pharmaceutical announced on February 14 that it has received manufacturing approval for Grelan Bit, its proprietary over-the-counter drug for fever and headache, from the Ministry of Health, Labor and Welfare. A successor drug to its existing product Grelan Ace, ASKA Pharmaceutical's new product contains ibuprofen ibuprofen (ī`by  prō'fən), nonsteroidal anti-inflammatory drug (NSAID) that reduces pain, fever, and inflammation. and acetaminophen acetaminophen (əsēt'əmĭn`əfĭn), an analgesic and fever-reducing medicine similar in effect to aspirin. It is an active ingredient in many over-the-counter medicines, including Tylenol and Midol. at a ratio of 2:1 and exerts a stronger analgesic effect while reducing gastric upset. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion